G
Goldline Pharmaceutical Ltd.
SMEBSEListedListed on 19 May 2026+39.0%
₹41–43
₹ 8 Cr
6000 Shares
₹ 2,46,000
₹10
Historical Financials
Annual standalone figures
| Particulars | FY 2023-24 | FY 2024-25 | FY 2025-26 |
|---|---|---|---|
| 2,356.6 | 2,805.57 | 3,119.76 | |
| 0 | 0 | 0.11 | |
| 2,356.6 | 2,805.57 | 3,119.87 | |
| 1,926.18 | 2,199.99 | 2,411.67 | |
| 252.69 | 385.84 | 538.54 | |
| 180.6 | 283.43 | 411.71 | |
| 786.54 | 1,026.03 | 1,424.96 | |
| 572.61 | 564.96 | 595.04 | |
| 3.01 | 4.11 | 5.97 | |
| 35.62 | 39.06 | 39.41 | |
| 292.24 | 318.12 | 281.46 | |
| -110.88 | 16.23 | -5.78 | |
| -107.79 | -289.43 | -340.41 | |
| 73.57 | 44.92 | -64.73 | |
| Closing Cash (₹ Mn) | 78.99 | 123.97 | 59.24 |